Picture of Flerie AB logo

FLERIE Flerie AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Index Pharmaceuticals Gets Patent For Additional DIMS Compounds Granted In Europe

April 7 (Reuters) - InDex Pharmaceuticals Holding AB
 INDEX.ST :
    * INDEX PHARMACEUTICALS GETS PATENT FOR ADDITIONAL DIMS
COMPOUNDS
GRANTED IN EUROPE
    * THAT A PATENT COVERING 19 COMPOUNDS FROM COMPANY'S DIMS
PLATFORM
HAS BEEN GRANTED BY EUROPEAN PATENT OFFICE
    * PATENT WAS FILED IN 2011 AND PROVIDES AN EXCLUSIVITY
PERIOD
UNTIL DECEMBER 2031, WITH POSSIBILITY OF UP TO 5 YEARS TERM
EXTENSION AFTER MARKET APPROVAL

Source text for Eikon:  ID:nWkr1r4DrQ 
Further company coverage:  INDEX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Flerie AB

See all news